ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia

Détails

Demande d'une copieDemande d'une copie
ID Serval
serval:BIB_B564A8C309EE
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Production externe
Titre
ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia
Périodique
Pharmacogenomics
Auteur⸱e⸱s
L'Huillier Arnaud, Ing Lorenzini Kuntheavy, Crisinel Pierre-Alex, Rebsamen Michela, Fluss Joel Victor, Barbe Remy, Siegrist Claire-Anne, Dayer Pierre, Posfay Barbe Klara Maria, Desmeules Jules Alexandre
ISSN
1462-2416
Statut éditorial
Publié
Date de publication
2011
Volume
12
Numéro
10
Pages
1493-501
Langue
anglais
Notes
Collaborators (26)
Wildhaber B......
Résumé
To examine the safety profile of oseltamivir in children and evaluate the impact of P-glycoprotein polymorphisms on the incidence of neuropsychiatric adverse events (NPAE) in oseltamivir-treated children.
Mots-clé
Adolescent, Antiviral Agents/adverse effects/therapeutic use, Blood-Brain Barrier/drug effects, Capillary Permeability/drug effects/genetics, Child, Child, Preschool, Humans, Infant, Infant, Newborn, Influenza A Virus, H1N1 Subtype, Influenza, Human/drug therapy, Mental Disorders/chemically induced/genetics, Oseltamivir/adverse effects/therapeutic use, P-Glycoprotein/genetics, Pandemics, Polymorphism, Single Nucleotide
DOI
10.2217/pgs.11.91
Pubmed
21902503
Création de la notice
25/11/2016 12:49
Dernière modification de la notice
03/06/2020 8:01
Données d'usage